about
Liuwei Dihuang Pills Enhance the Effect of Western Medicine in Treating Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled TrialsThe endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyBardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic miceThe continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue.Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markersObesity and diabetic kidney disease.Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers.Why is organ transplantation clinically important?Protective effects of Danggui Buxue Tang on renal function, renal glomerular mesangium and heparanase expression in rats with streptozotocin-induced diabetes mellitus.Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension).The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).Are post-trial observational studies useful?Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus.Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
P2860
Q26753148-BC925EDA-79FD-4707-B621-C72807DE166DQ28237978-54FDD8E2-A16F-4D1F-BDBE-243ED4ED736DQ34383685-5D719A3B-3C14-40BD-82EE-FADD3A3F3B6BQ35126070-5EA92E80-3CAB-484B-882B-2993DD10B9DCQ35585328-202D3560-9A68-44EE-8C05-1F596EF776F7Q35760275-9E56CBE4-CA17-4813-AF40-A61E6434F276Q35813371-DEAA50C0-09DE-4731-BB47-B2B5BA38265FQ36125465-81DE9C46-A772-4D24-9EC8-763F829F6094Q36515043-383B9C28-93B3-40F9-B201-8A6952389985Q36550886-54FBE754-ABE8-47F2-88A3-5242DB28FF0BQ36851156-0B50075A-7D33-493C-A9B1-8BEE1591A010Q36870263-DD009D90-8EF2-4802-90BA-C990A42E73AFQ36954021-40289C55-D4AF-42EB-B786-9AB1717CB3CAQ37019804-F1BC619C-DD69-4B97-AED1-88263CF01BF0Q37369476-EA7A6C20-B2E2-425F-AC54-98F3415B0DA5Q38174491-BC242444-25E4-42DD-9733-85851A7899A0Q38663562-C9976DD4-D5D9-406C-B557-BEEC3104568AQ38927264-BF98D696-D50F-4749-B64D-CAD4AB332067Q40675012-1CFDC6D4-A2C0-4387-97E1-004BF493D115Q42272174-1AB33223-C6DC-4940-B513-365B65D999B0Q42920085-487F3C7A-A91E-40C4-961C-C8FC59E70BA2Q52884442-AF2C6269-8CC6-4250-8189-6826F71859CCQ53154010-3C082A71-569C-48BE-A537-BD0AB33ECD1D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The kidney in type 2 diabetes therapy
@ast
The kidney in type 2 diabetes therapy
@en
type
label
The kidney in type 2 diabetes therapy
@ast
The kidney in type 2 diabetes therapy
@en
prefLabel
The kidney in type 2 diabetes therapy
@ast
The kidney in type 2 diabetes therapy
@en
P2860
P356
P1476
The kidney in type 2 diabetes therapy
@en
P2093
Dick de Zeeuw
Hiddo J Lambers Heerspink
P2860
P304
P356
10.1900/RDS.2011.8.392
P577
2011-11-10T00:00:00Z